SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001354488-15-004934
Filing Date
2015-11-10
Accepted
2015-11-10 16:02:46
Documents
16
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT opxa_10q.htm 10-Q 697981
2 CERTIFICATE OF AMENDMENT TO THE RESTATED CERTIFICATE OF FORMATION opxa_ex31.htm EX-3.2 2773
3 CERTIFICATION opxa_ex311.htm EX-31.1 15338
4 CERTIFICATION opxa_ex312.htm EX-31.2 15338
5 CERTIFICATION opxa_ex321.htm EX-32.1 7796
6 CERTIFICATION opxa_ex322.htm EX-32.2 7601
7 opexa.jpg GRAPHIC 2634
8 page_2.jpg GRAPHIC 168204
9 page_3.jpg GRAPHIC 286912
10 page_4.jpg GRAPHIC 79646
  Complete submission text file 0001354488-15-004934.txt   2567053

Data Files

Seq Description Document Type Size
11 opxa-20150930.xml EX-101.INS 144433
12 opxa-20150930.xsd EX-101.SCH 25157
13 opxa-20150930_cal.xml EX-101.CAL 30664
14 opxa-20150930_lab.xml EX-101.LAB 166433
15 opxa-20150930_pre.xml EX-101.PRE 110473
16 opxa-20150930_def.xml EX-101.DEF 35207
Mailing Address 2635 TECHNOLOGY FOREST BLVD. THE WOODLANDS TX 77381
Business Address 2635 TECHNOLOGY FOREST BLVD. THE WOODLANDS TX 77381 (281) 272-9331
Opexa Therapeutics, Inc. (Filer) CIK: 0001069308 (see all company filings)

IRS No.: 760333165 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33004 | Film No.: 151218868
SIC: 2834 Pharmaceutical Preparations